Clinical trial
Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow…
NCT00038779 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00038779 |
|---|---|
| Title | Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States |
| Official title | Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Leukemia, Non Hodgkin's Lymphoma, Aplastic Anemia |
| Intervention type | Procedure |
| Interventions | Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation |
| Enrollment | 7 |
| Start date | Aug 14, 1996 |
| Primary completion | Sep 20, 2004 |
| Completion | Sep 20, 2004 |
| First posted | Jun 7, 2002 |
| Last update posted | Oct 30, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: